DaVita
Headquarters as seen from the Denver Millennium Bridge | |
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 1992 |
| Headquarters | Denver, Colorado, U.S. |
Key people | Javier J. Rodriguez (CEO) |
| Services | Kidney dialysis |
| Revenue | US$13.653 billion (2025) |
| US$2.043 billion (2025) | |
| US$1.078 billion (2025) | |
| Total assets | US$17.480 billion (2025) |
| Total equity | -US$651 million (2025) |
| Owner | Berkshire Hathaway (41.2%) |
Number of employees | 78,000 (2025) |
| Website | davita |
| Footnotes / references | |
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language), incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients (36% of the total of 557,000 patients in the U.S.), and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500.